Table 2. Comparison of functional and strength related assessments between groups.
| Control (n=17) | Experimental (n=16) | p* | |||
| Median | IQR 25th-75th | Median IQR 25th-75th | |||
| Fugl-Meyer Assessment | |||||
| Baseline | 51 | 49-54 | 51 | 50-53 | 0,958 |
| At the end of treatment | 57 | 55-58 | 56,5 | 55,5-59 | 0,606 |
| Follow-up | 61 | 57-62 | 60 | 58-62 | 0,845 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.001¶ | 0.001¶ | ||||
| Box and Block Test | |||||
| Baseline | 28 | 21-31 | 24,5 | 16-30,5 | 0,606 |
| At the end of treatment | 36 | 27-42 | 41 | 22,5-49 | 0,488 |
| Follow-up | 38 | 34-49 | 48 | 31.5-55.5 | 0,191 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.015¶ | 0.001¶ | ||||
| Nine Hole Peg Test | |||||
| Baseline | 60 | 45.3-136.3 | 143,2 | 53,5-195 | 0,309 |
| At the end of treatment | 34,5 | 28.8-59.9 | 48,7 | 30,4-95 | 0,488 |
| Follow-up | 32,5 | 27.3-70.6 | 40,4 | 25.3-90.0 | 0,683 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.653¶ | 0.001¶ | ||||
| Jebsen Taylor Hand Function Test | |||||
| Baseline | 105,2 | 69-134.8) | 119,3 | 91.1-213.5 | 0,326 |
| At the end of treatment | 56,5 | 46.9-106.2 | 62,6 | 44.9-109.7 | 0,845 |
| Follow-up | 56,8 | 44.9-91.2 | 49,1 | 39.1-86.2 | 0,465 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.619¶ | p3<0.001¶ | ||||
| Pinch strength | |||||
| Baseline | 4 | 3-5 | 4 | 2-6 | 0,817 |
| At the end of treatment | 5 | 4-6 | 5,5 | 3,5-8 | 0,276 |
| Follow-up | 5 | 4-7 | 6,5 | 5-11 | 0,157 |
| p# | <0.001 | <0.001 | |||
| 0.034† | 0.004† | ||||
| 0.0021‡ | <0.0011‡ | ||||
| 0.016¶ | 0.005¶ | ||||
| Grip strength | |||||
| Baseline | 10 | 6-15 | 12,5 | 8-20 | 0,465 |
| At the end of treatment | 12 | 10-20 | 15 | 12-25 | 0,276 |
| Follow-up | 12 | 10-20 | 20 | 12-30 | 0,136 |
| p# | <0.001 | <0.001 | |||
| 0.001† | 0.003† | ||||
| 0.0011‡ | 0.0011‡ | ||||
| 0.551¶ | 0.015¶ | ||||
| IQR: Interquartile range; * Mann-Whitney U test; # Friedman test; † Baseline vs. at the end of the treatment; ‡ Baseline vs. follow-up; ¶ At the end of the treatment vs. follow up, p<0.05. | |||||